Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

PTC Therapeutics, Inc. (PTCT) News - StockMarketCap

Stocks›PTC Therapeutics, Inc.☆

● At closeAs of Jul 2, 2026

PTC Therapeutics, Inc.

PTCT✓

HealthcareBiotechnologyNASDAQ

$83.31+2.41%

$6.91BMarket cap

-35.47xP/E ratio

1.67MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$83.31

$1.96 (+2.41%) · 24h

Key metrics

Market cap$6.91B+10.53%

Enterprise value$6.43B

Volume (24h)1.67M

P/E ratio (TTM)-35.47x

P/S ratio (TTM)8.30x

Dividend yield0.00%

Shares outstanding82.95M

Trading range

Previous close$81.35

Day range$80.77 - $83.37

52-week range$43.18 - $87.50

PTC Therapeutics, Inc. (PTCT) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news